Application 209923
- Type
- ANDA
- Sponsor
- PRINSTON PHARMA INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOFACITINIB | TOFACITINIB | TABLET;ORAL | 5MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tofacitinib | TOFACITINIB | XLCare Pharmaceuticals Inc | 10403307-e2f9-44d1-bc72-552fdba299d1 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Macleods Pharmaceuticals Limited | 9b654f0d-7705-4880-9e9d-ad3a51e56b56 | 2026-10-22 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Apotex Corp. | 7d4f5cfa-35a8-1458-a609-f6b417946abb | 2026-10-21 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Sun Pharmaceutical Industries, Inc. | a764a133-b870-4514-bbee-24d43f8cb7fd | 2026-10-16 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| Tofacitinib | TOFACITINIB | Saptalis Pharmaceuticals, LLC. | c6c033ff-bce0-4d1c-a182-3b13191686e1 | 2026-10-15 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 179ffbb2-bedc-40e6-b77b-33d4f7832172 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Apotex Corp. | dd62a2b8-300b-d92b-7b27-a30eaa68fdd3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib XR | TOFACITINIB | Biocon Pharma Inc | f0160e3d-63ea-75fb-4b88-fe3d6a6ce030 | 2026-10-07 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| XELJANZ | TOFACITINIB | U.S. Pharmaceuticals | 68e3d6b2-7838-4d2d-a417-09d919b43e13 | 2026-10-06 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | Ajanta Pharma USA Inc. | 024bb9f2-8c26-4d9d-a33b-eb3c0a7c59ed | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| tofacitinib | TOFACITINIB | Zydus Pharmaceuticals USA Inc. | 21a89264-8047-40ac-8b10-fa6461072509 | 2026-10-05 | Boxed warning, Warnings, Adverse reactions | tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Bryant Ranch Prepack | 89211a4d-befb-40f1-8792-aa599fdd794c | 2026-10-02 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Micro Labs Limited | ffa6819b-23a4-478b-8fb7-cc90e8142fc5 | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| tofacitinib solution | TOFACITINIB | Hikma Pharmaceuticals USA Inc. | d9cf18a9-e825-49ac-b080-68957c0e79ae | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB |
| Tofacitinib | TOFACITINIB | Novadoz Pharmaceuticals LLC | 253635c8-1ea7-41ba-b216-dea5e3305c47 | 2026-09-01 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Novadoz Pharmaceuticals LLC | 327f6b60-1a5d-49e6-acff-18603d0ee9d0 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
| Tofacitinib | TOFACITINIB | Edenbridge Pharmaceuticals LLC. | 576722e5-6639-452d-a5c3-33a064f19481 | 2026-08-17 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | Golden State Medical Supply, Inc. | 58f22c41-87d2-e745-e063-6394a90a962e | 2026-08-13 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| Tofacitinib | TOFACITINIB | AvKARE | 5751321a-c904-44ae-e063-6394a90a2654 | 2026-07-23 | Boxed warning, Warnings, Adverse reactions | Tofacitinib TOFACITINIB |
| TOFACITINIB | TOFACITINIB | Aurobindo Pharma Limited | e54b186f-e42a-4477-939c-8dd331045fbe | 2026-07-17 | Boxed warning, Warnings, Adverse reactions | TOFACITINIB TOFACITINIB |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 55953 | ORIG | 2018-10-17 |